✦ LIBER ✦

The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma

✍ Scribed by Yan Zhang; Yanyan Jia; Xinyou Liu; Linna Liu; Qingwei Wang; Aidong Wen

Publisher: Springer
Year: 2009
Tongue: English
Weight: 268 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1040-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of kanglaite capsules combined w

Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC)

✍ Daojun Li; Xinhua Xu; Dan Bao; Feng Xue; Delan Dai 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 256 KB

Midterm outcomes in patients with interm

Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma : A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization

✍ Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

The safety and efficacy of transcatheter

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction : A prospective controlled study

✍ Hyo-Suk Lee; Joo Sung Kim; Il Ju Choi; Jin Wook Chung; Jae Hyung Park; Chung Yon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 3 views

## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co

Effect of repeated transcatheter arteria

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model

✍ Kenji Ikeda; Hiromitsu Kumada; Satoshi Saitoh; Yasuji Arase; Kazuaki Chayama 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 2 views

A phase I-II trial of mitoxantrone by he

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver

✍ Dennie V. Jones Jr.; Yehuda Z. Patt; Jaffer A. Ajani; James Abbruzzese; Bernard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views